Literature DB >> 10455109

Identification of amino acid residues responsible for the pyrimidine and purine nucleoside specificities of human concentrative Na(+) nucleoside cotransporters hCNT1 and hCNT2.

S K Loewen1, A M Ng, S Y Yao, C E Cass, S A Baldwin, J D Young.   

Abstract

hCNT1 and hCNT2 mediate concentrative (Na(+)-linked) cellular uptake of nucleosides and nucleoside drugs by human cells and tissues. The two proteins (650 and 658 residues, 71 kDa) are 72% identical in sequence and contain 13 putative transmembrane helices (TMs). When produced in Xenopus oocytes, recombinant hCNT1 is selective for pyrimidine nucleosides (system cit), whereas hCNT2 is selective for purine nucleosides (system cif). Both transport uridine. We have used (i) chimeric constructs between hCNT1 and hCNT2, (ii) sequence comparisons with a newly identified broad specificity concentrative nucleoside transporter (system cib) from Eptatretus stouti, the Pacific hagfish (hfCNT), and (iii) site-directed mutagenesis of hCNT1 to identify two sets of adjacent residues in TMs 7 and 8 of hCNT1 (Ser(319)/Gln(320) and Ser(353)/Leu(354)) that, when converted to the corresponding residues in hCNT2 (Gly(313)/Met(314) and Thr(347)/Val(348)), changed the specificity of the transporter from cit to cif. Mutation of Ser(319) in TM 7 of hCNT1 to Gly enabled transport of purine nucleosides, whereas concurrent mutation of Gln(320) to Met (which had no effect on its own) augmented this transport. The additional mutation of Ser(353) to Thr in TM 8 converted hCNT1/S319G/Q320M, from cib to cif, but with relatively low adenosine transport activity. Additional mutation of Leu(354) to Val (which had no effect on its own) increased the adenosine transport capability of hCNT1/S319G/Q320M/S353T, producing a full cif-type transporter phenotype. On its own, the S353T mutation converted hCNT1 into a transporter with novel uridine-selective transport properties. Helix modeling of hCNT1 placed Ser(319) (TM 7) and Ser(353) (TM 8) within the putative substrate translocation channel, whereas Gln(320) (TM 7) and Leu(354) (TM 8) may exert their effects through altered helix packing.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10455109     DOI: 10.1074/jbc.274.35.24475

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Cysteine-accessibility analysis of transmembrane domains 11-13 of human concentrative nucleoside transporter 3.

Authors:  Jing Zhang; Tracey Tackaberry; Mabel W L Ritzel; Taylor Raborn; Gerry Barron; Stephen A Baldwin; James D Young; Carol E Cass
Journal:  Biochem J       Date:  2006-03-01       Impact factor: 3.857

2.  Electrophysiological characterization of a recombinant human Na+-coupled nucleoside transporter (hCNT1) produced in Xenopus oocytes.

Authors:  Kyla M Smith; Amy M L Ng; Sylvia Y M Yao; Kathy A Labedz; Edward E Knaus; Leonard I Wiebe; Carol E Cass; Stephen A Baldwin; Xing-Zhen Chen; Edward Karpinski; James D Young
Journal:  J Physiol       Date:  2004-06-11       Impact factor: 5.182

Review 3.  The concentrative nucleoside transporter family, SLC28.

Authors:  Jennifer H Gray; Ryan P Owen; Kathleen M Giacomini
Journal:  Pflugers Arch       Date:  2003-07-11       Impact factor: 3.657

4.  Conserved glutamate residues Glu-343 and Glu-519 provide mechanistic insights into cation/nucleoside cotransport by human concentrative nucleoside transporter hCNT3.

Authors:  Melissa D Slugoski; Kyla M Smith; Amy M L Ng; Sylvia Y M Yao; Edward Karpinski; Carol E Cass; Stephen A Baldwin; James D Young
Journal:  J Biol Chem       Date:  2009-04-20       Impact factor: 5.157

5.  Genomic organization and functional characterization of the human concentrative nucleoside transporter-3 isoform (hCNT3) expressed in mammalian cells.

Authors:  Shuy-Vang Toan; Kenneth K W To; George P H Leung; Maria Olivia de Souza; Jeffrey L Ward; Chung-Ming Tse
Journal:  Pflugers Arch       Date:  2003-09-18       Impact factor: 3.657

6.  A conformationally mobile cysteine residue (Cys-561) modulates Na+ and H+ activation of human CNT3.

Authors:  Melissa D Slugoski; Kyla M Smith; Ras Mulinta; Amy M L Ng; Sylvia Y M Yao; Ellen L Morrison; Queenie O T Lee; Jing Zhang; Edward Karpinski; Carol E Cass; Stephen A Baldwin; James D Young
Journal:  J Biol Chem       Date:  2008-07-11       Impact factor: 5.157

7.  A proton-mediated conformational shift identifies a mobile pore-lining cysteine residue (Cys-561) in human concentrative nucleoside transporter 3.

Authors:  Melissa D Slugoski; Amy M L Ng; Sylvia Y M Yao; Kyla M Smith; Colin C Lin; Jing Zhang; Edward Karpinski; Carol E Cass; Stephen A Baldwin; James D Young
Journal:  J Biol Chem       Date:  2008-01-16       Impact factor: 5.157

8.  Crystal structure of a concentrative nucleoside transporter from Vibrio cholerae at 2.4 Å.

Authors:  Zachary Lee Johnson; Cheom-Gil Cheong; Seok-Yong Lee
Journal:  Nature       Date:  2012-03-11       Impact factor: 49.962

9.  Efficiency of purine utilization by Helicobacter pylori: roles for adenosine deaminase and a NupC homolog.

Authors:  Erica F Miller; Soumya Vaish; Robert J Maier
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

10.  Structural basis of nucleoside and nucleoside drug selectivity by concentrative nucleoside transporters.

Authors:  Zachary Lee Johnson; Jun-Ho Lee; Kiyoun Lee; Minhee Lee; Do-Yeon Kwon; Jiyong Hong; Seok-Yong Lee
Journal:  Elife       Date:  2014-07-31       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.